NASDAQ · Analyst Forecast

Senti Biosciences Holdings, Inc. (SNTI) Stock Forecast & Price Target

$0.10 NASDAQ: SNTI Market Cap $3.02M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Senti Biosciences Holdings, Inc. (SNTI), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Senti Biosciences Holdings, Inc., analysts forecast revenue rising from $1.00M in 2025 to $213.51M in 2030; the average estimate for 2030 earnings per share is $0.56; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$0.10
Consensus targetThe average of the price targets analysts have published.$6.00
Median targetThe middle target, less affected by a single outlier.$6.00
Highest targetThe most optimistic published target.$6.00
Lowest targetThe most pessimistic published target.$6.00
Difference from priceHow far the consensus target sits from today’s price.+5900.0%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.00M$1.00M$1.00M3
2026$16,000$16,000$16,0002
2027$100,000$100,000$100,0001
2028$20.60M$20.60M$20.60M2
2029$56.50M$56.50M$56.50M1
2030$213.51M$213.51M$213.51M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.96−$2.65−$2.063
2026−$0.78−$0.78−$0.782
2027−$0.96−$0.96−$0.961
2028−$2.22−$1.61−$1.002
2029−$1.42−$1.42−$1.421
2030$0.56$0.56$0.561

Senti Biosciences Holdings, Inc. (SNTI) forecast — frequently asked questions

What is the analyst price target for Senti Biosciences Holdings, Inc.?

Analysts covering Senti Biosciences Holdings, Inc. (SNTI) have a consensus price target of $6.00, 5900.0% above the current price of $0.10. Published targets range from $6.00 to $6.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Senti Biosciences Holdings, Inc.'s earnings?

The average analyst estimate for Senti Biosciences Holdings, Inc. (SNTI) earnings per share in 2030 is 0.56, with individual estimates between 0.56 and 0.56.

How much revenue is Senti Biosciences Holdings, Inc. expected to make?

Analysts forecast Senti Biosciences Holdings, Inc. (SNTI) revenue of $213.51M in 2030, based on 1 published estimates.

How many analysts cover SNTI?

3 analysts contribute estimates for Senti Biosciences Holdings, Inc. (SNTI). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.